Atlas Trials

Study of Oral Administration of Ribavirin and Nitazoxamide Versus Placebo in COVID-19

Clinical trial NCT04563208 · COMPLETED

Trial details

NCT number
NCT04563208
Sponsor
University of Witwatersrand, South Africa
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Covid19SARS-CoV Infection
Start date
2020-12-09
Primary completion
2022-02-28
Enrollment
80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.